These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24344482)

  • 21. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
    Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.
    Yang X; Fang W; Bargman JM; Oreopoulos DG
    Perit Dial Int; 2008; 28(1):82-92. PubMed ID: 18178952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to improve survival in geriatric peritoneal dialysis patients.
    Hiramatsu M;
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S185-9. PubMed ID: 17556302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment: case report.
    Próchnicka A; Olszowska A; Baczyński D; Zelichowski G; Lubas A; Wiśniewska M; Dziekiewicz M; Wańkowicz Z
    Pol Arch Med Wewn; 2009 Dec; 119(12):834-7. PubMed ID: 20010472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
    Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
    Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients with recurrent nephrosis and intractable edema by intraperitoneal instillation of icodextrin solution.
    Morimoto S; Takahashi N; Kikuchi S; Yamahara H; Imada T; Kohno K; Masaki H; Nishikawa M; Iwasaka T
    Perit Dial Int; 2008; 28(5):559-62. PubMed ID: 18708557
    [No Abstract]   [Full Text] [Related]  

  • 32. Icodextrin reduces the risk of congestive heart failure in peritoneal dialysis patients.
    Wang IK; Lin CL; Yen TH; Lin SY; Yao-Lung L; Sung FC
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):447-452. PubMed ID: 29490427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost savings from peritoneal dialysis therapy time extension using icodextrin.
    Johnson DW; Vincent K; Blizzard S; Rumpsfeld M; Just P
    Adv Perit Dial; 2003; 19():81-5. PubMed ID: 14763039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
    le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
    Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
    Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
    J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.
    Dallas F; Jenkins SB; Wilkie ME
    Perit Dial Int; 2004; 24(6):542-6. PubMed ID: 15559483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.
    Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC;
    Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
    Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
    Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icodextrin and peritoneal dialysis: advantages and new applications.
    Dousdampanis P; Musso CG; Trigka K
    Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.